Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR8A1 Inhibitors

Olfactory receptor 8A1 (OR8A1) is a member of the olfactory receptor family, which is a large group of G-protein-coupled receptors (GPCRs) that play a critical role in the sense of smell. Olfactory receptors are responsible for detecting volatile odorant molecules and are primarily expressed in the olfactory epithelium, the specialized tissue within the nasal cavity. OR8A1, like other olfactory receptors, is involved in initiating the signal transduction pathway that begins when an odorant binds to its receptor. Upon binding, OR8A1 undergoes a conformational change, activating the associated G-protein, typically G_olf in olfactory sensory neurons. The activated G-protein then stimulates the production of cyclic adenosine monophosphate (cAMP) via adenylate cyclase. Increased levels of cAMP open cyclic nucleotide-gated ion channels, leading to an influx of calcium and sodium ions into the cell, which ultimately results in depolarization of the neuron and the transmission of an electrical signal to the brain.The brain interprets signals from a vast array of olfactory receptors, such as OR8A1, to perceive and discriminate an enormous variety of chemical compounds as distinct odors. Each olfactory receptor, including OR8A1, is tuned to detect a particular set of molecules, contributing to the complexity of scent perception.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

A non-selective beta-adrenergic receptor blocker that can indirectly affect GPCR signaling pathways.

Ondansetron

99614-02-5sc-201127
sc-201127A
10 mg
50 mg
$82.00
$333.00
1
(0)

A serotonin 5-HT3 receptor antagonist, illustrating the potential for specific GPCR modulation.

Losartan

114798-26-4sc-353662
100 mg
$130.00
18
(1)

An angiotensin II receptor antagonist, affecting GPCR-mediated signaling in cardiovascular systems.

(RS)-Atenolol

29122-68-7sc-204895
sc-204895A
1 g
10 g
$79.00
$416.00
1
(1)

A selective beta1-adrenergic receptor blocker, used to showcase GPCR pathway modulation.

Clozapine

5786-21-0sc-200402
sc-200402A
sc-200402B
sc-200402C
50 mg
500 mg
5 g
10 g
$69.00
$364.00
$2500.00
$4100.00
11
(1)

An antipsychotic that acts on various GPCRs, including dopamine and serotonin receptors.

Diltiazem

42399-41-7sc-204726
sc-204726A
1 g
5 g
$209.00
$464.00
4
(1)

A calcium channel blocker that indirectly affects GPCR signaling involved in cardiac function.

Cimetidine

51481-61-9sc-202996
sc-202996A
5 g
10 g
$62.00
$86.00
1
(1)

A histamine H2 receptor antagonist, illustrating GPCR involvement in gastric acid secretion.

Haloperidol

52-86-8sc-507512
5 g
$190.00
(0)

An antipsychotic that targets dopamine receptors, another example of GPCR modulation.

Ranitidine

66357-35-5sc-203679
1 g
$193.00
(1)

Another histamine H2 receptor antagonist, used for its effect on gastric acid secretion via GPCRs.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$124.00
$240.00
$530.00
$999.00
$1530.00
2
(1)

A non-selective beta-adrenergic blocker with additional alpha-blocking activity, affecting GPCR signaling.